WashU Med researcher urges public to take first vaccine available

View Content

Rachel Presti, MD, PhD, an infectious disease physician who led WashU Med’s participation in the Johnson & Johnson/Janssen COVID-19 vaccine trial, encourages the public to take the first vaccine available to them. 

Presti’s team conducted their clinical trial for several months — as the St. Louis area saw massive spikes in COVID-19 cases — and found the vaccine’s effectiveness to be comparable with those from Pfizer-BioNTech and Moderna.

“Whatever vaccine the different community locations offer, take it,” Presti said. “All three vaccines authorized for use in the U.S. have been shown to provide safe and highly effective protection against serious illness, hospitalization and death due to COVID-19.”

To learn more, visit the WashU Med news hub.